Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential

Mesenchymal stem cells (MSCs) are effective therapeutic agents that contribute to tissue repair and regeneration by secreting various factors. However, donor-dependent variations in MSC proliferation and therapeutic potentials result in variable production yields and clinical outcomes, thereby imped...

Full description

Saved in:
Bibliographic Details
Main Authors: Sun Jeong Kim, Sang Eon Park, Jang Bin Jeong, Shin Ji Oh, Alee Choi, Yun Hee Kim, Suk-joo Choi, Soo-young Oh, Gyu Ha Ryu, Hong Bae Jeon, Jong Wook Chang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2022/4711499
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548345526091776
author Sun Jeong Kim
Sang Eon Park
Jang Bin Jeong
Shin Ji Oh
Alee Choi
Yun Hee Kim
Suk-joo Choi
Soo-young Oh
Gyu Ha Ryu
Hong Bae Jeon
Jong Wook Chang
author_facet Sun Jeong Kim
Sang Eon Park
Jang Bin Jeong
Shin Ji Oh
Alee Choi
Yun Hee Kim
Suk-joo Choi
Soo-young Oh
Gyu Ha Ryu
Hong Bae Jeon
Jong Wook Chang
author_sort Sun Jeong Kim
collection DOAJ
description Mesenchymal stem cells (MSCs) are effective therapeutic agents that contribute to tissue repair and regeneration by secreting various factors. However, donor-dependent variations in MSC proliferation and therapeutic potentials result in variable production yields and clinical outcomes, thereby impeding MSC-based therapies. Hence, selection of MSCs with high proliferation and therapeutic potentials would be important for effective clinical application of MSCs. This study is aimed at identifying the upregulated genes in human Wharton’s jelly-derived MSCs (WJ-MSCs) with high proliferation potential using mRNA sequencing. Aurora kinase A (AURKA) and dedicator of cytokinesis 2 (DOCK2) were selected as the upregulated genes, and their effects on proliferation, migration, and colony formation of the WJ-MSCs were verified using small interfering RNA (siRNA) techniques. mRNA expression levels of both the genes were positively correlated with the proliferation capacity of WJ-MSCs. Moreover, AURKA from human WJ-MSCs regulated the antiapoptotic effect of skeletal muscle cells by upregulating the chemokine (C motif) ligand (XCL1); this was further confirmed in the mdx mouse model. Taken together, the results indicated that AURKA and DOCK2 can be used as potential biomarkers for proliferation and migration of human WJ-MSCs. In particular, human WJ-MSCs with high expression of AURKA might have therapeutic efficacy against muscle diseases, such as Duchenne muscular dystrophy (DMD).
format Article
id doaj-art-acf4e35b797c4df39fe1246d49f773c3
institution Kabale University
issn 1687-9678
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-acf4e35b797c4df39fe1246d49f773c32025-02-03T06:14:20ZengWileyStem Cells International1687-96782022-01-01202210.1155/2022/4711499Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic PotentialSun Jeong Kim0Sang Eon Park1Jang Bin Jeong2Shin Ji Oh3Alee Choi4Yun Hee Kim5Suk-joo Choi6Soo-young Oh7Gyu Ha Ryu8Hong Bae Jeon9Jong Wook Chang10Stem Cell InstituteStem Cell InstituteStem Cell InstituteStem Cell InstituteStem Cell InstituteStem Cell InstituteDepartment of Obstetrics and GynecologyDepartment of Obstetrics and GynecologyDepartment of Medical Device Management and ResearchStem Cell InstituteStem Cell InstituteMesenchymal stem cells (MSCs) are effective therapeutic agents that contribute to tissue repair and regeneration by secreting various factors. However, donor-dependent variations in MSC proliferation and therapeutic potentials result in variable production yields and clinical outcomes, thereby impeding MSC-based therapies. Hence, selection of MSCs with high proliferation and therapeutic potentials would be important for effective clinical application of MSCs. This study is aimed at identifying the upregulated genes in human Wharton’s jelly-derived MSCs (WJ-MSCs) with high proliferation potential using mRNA sequencing. Aurora kinase A (AURKA) and dedicator of cytokinesis 2 (DOCK2) were selected as the upregulated genes, and their effects on proliferation, migration, and colony formation of the WJ-MSCs were verified using small interfering RNA (siRNA) techniques. mRNA expression levels of both the genes were positively correlated with the proliferation capacity of WJ-MSCs. Moreover, AURKA from human WJ-MSCs regulated the antiapoptotic effect of skeletal muscle cells by upregulating the chemokine (C motif) ligand (XCL1); this was further confirmed in the mdx mouse model. Taken together, the results indicated that AURKA and DOCK2 can be used as potential biomarkers for proliferation and migration of human WJ-MSCs. In particular, human WJ-MSCs with high expression of AURKA might have therapeutic efficacy against muscle diseases, such as Duchenne muscular dystrophy (DMD).http://dx.doi.org/10.1155/2022/4711499
spellingShingle Sun Jeong Kim
Sang Eon Park
Jang Bin Jeong
Shin Ji Oh
Alee Choi
Yun Hee Kim
Suk-joo Choi
Soo-young Oh
Gyu Ha Ryu
Hong Bae Jeon
Jong Wook Chang
Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
Stem Cells International
title Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
title_full Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
title_fullStr Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
title_full_unstemmed Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
title_short Wharton’s Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
title_sort wharton s jelly derived mesenchymal stem cells with high aurora kinase a expression show improved proliferation migration and therapeutic potential
url http://dx.doi.org/10.1155/2022/4711499
work_keys_str_mv AT sunjeongkim whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT sangeonpark whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT jangbinjeong whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT shinjioh whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT aleechoi whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT yunheekim whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT sukjoochoi whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT sooyoungoh whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT gyuharyu whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT hongbaejeon whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential
AT jongwookchang whartonsjellyderivedmesenchymalstemcellswithhighaurorakinaseaexpressionshowimprovedproliferationmigrationandtherapeuticpotential